How many times did Damian say 'nadir'?
Are there still too many biotech companies? How do you know when you're in a bubble? And is there a wrong way to pronounce "TIGIT"?
We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine. LISTEN NOW Subscribe to the podcast to never miss an episode Visit the archive to see past episodes |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments